Patent Oppositions in organic medicines industry

Explore the competitive field of organic medicines where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in organic medicines technology and learn how to protect your intellectual property.

Get Patent Opposition Report for organic medicines

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Oct 2, 2025
CompanyTotal Oppositions
NOVARTIS258
BOEHRINGER INGELHEIM98
PFIZER79
CELGENE63
NUTRICIA60
NESTLE55
JANSSEN PHARMACEUTICA51
AMGEN50
NESTEC50
EURO CELTIQUE43

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the organic medicines industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the organic medicines industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the organic medicines industry

Lipid Nanoparticle FormulationMODERNAAug 26, 2025PFIZER
Preparation Containing Tetracyclic Compound At High DoseCHUGAI SEIYAKU KABUSHIKI KAISHAAug 20, 2025ELKINGTON AND FIFE
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNAAug 20, 2025MAIWALD
Preparation Containing Tetracyclic Compound At High DoseCHUGAI SEIYAKU KABUSHIKI KAISHAAug 19, 2025TEVA PHARMACEUTICALS
Use Of Migalostat In Reducing The Risk Of Cerebrovascular Event In Patients With Fabry DiseaseAMICUS THERAPEUTICSAug 13, 2025TEVA PHARMACEUTICALS
Composition Comprising Epa, Ma And Leucine For Improving Muscle FunctionNUTRICIAAug 13, 2025FRESENIUS KABI DEUTSCHLAND
Treatment Of Prostate CancerTAKEDA PHARMACEUTICALAug 7, 2025ABG LAW
Tablets Comprising Eltrombopag OlamineNOVARTISAug 5, 2025STADA ARZNEIMITTEL
Compositions For Use In Improving Stool Consistency Or Frequency In Infants Or Young ChildrenNESTECJul 29, 2025CHR HANSEN
Palatable Antiparasitic FormulationsZOETIS SERVICESJul 29, 2025VIRBAC

To stay ahead in the competitive organic medicines industry, companies are constantly innovating. Here are the top patents facing oppositions in the organic medicines industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
Apr 14, 2021Methods And Compositions For Treating CancerJANSSEN ONCOLOGY22
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA20
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS18
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM18
Oct 11, 2023New UseNOVARTIS16
Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPE15
Mar 8, 2023Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS15
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMA13
Nov 13, 2019Apixaban FormulationsPFIZER12